Manish Ranjan

Employment

• Baylor College of Medicine Postdoctoral Associate
  2022 - Present
• Northwestern Medicine Postdoctoral Fellow
  2015 - 2018

Education

• Tulane University School of Medicine Ph.D
  2011 - Present

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• DRIMS: A Synthetic Biology Platform that Enables Deletion, Replacement, Insertion, Mutagenesis, and Synthesis of DNA
  ACS Synthetic Biology 2025 DOI: 10.1021/ACSSYNBIO.4C00649
  +Save
• Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers
  Cancers 2024 DOI: 10.3390/cancers16132462
  +Save
• ESR1 and p53 interactome alteration defines mechanisms of tamoxifen response in luminal breast cancer
  IScience 2024 DOI: 10.1016/J.ISCI.2024.109995
  +Save
• Author Correction: Lipid exposure activates gene expression changes associated with estrogen receptor negative breast cancer
  npj Breast Cancer 2023 DOI: 10.1038/s41523-023-00516-3
  +Save
• Lipid exposure activates gene expression changes associated with estrogen receptor negative breast cancer
  npj Breast Cancer 2022 DOI: 10.1038/s41523-022-00422-0
  +Save
• Patient-Derived Xenograft Models for Studying Vascular Mimicry in Melanoma In Vivo
  Methods in Molecular Biology 2022 DOI: 10.1007/978-1-0716-2403-6_9
  +Save
• Progesterone receptor antagonists reverse stem cell expansion and the paracrine effectors of progesterone action in the mouse mammary gland.
  Breast cancer research : BCR 2021 DOI: 10.1186/s13058-021-01455-2
  +Save
• Orthopedics
  Toxicological Aspects of Medical Device Implants 2020 DOI: 10.1016/b978-0-12-820728-4.00010-1
  +Save
• Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer
  International Journal of Cancer 2017 DOI: 10.1002/ijc.30680
  +Save
• Nanotechnology combined therapy: tyrosine kinase-bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model
  BJU International 2017 DOI: 10.1111/bju.13590
  +Save